• 1. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 2. Fe3O4 nanoclusters highly dispersed on a porous graphene support as an additive for improving the hydrogen storage properties of LiBH4?
  Guang Xu,Wei Zhang,Ying Zhang,Xiaoxia Zhao,Ping Wen,Di Ma RSC Adv., 2018,8, 19353-19361
• 3. Fe3O4/PEG-SO3H as a heterogeneous and magnetically-recyclable nanocatalyst for the oxidation of sulfides to sulfones or sulfoxides
  Saeideh Mirfakhraei,Malak Hekmati,Fereshteh Hosseini Eshbala,Hojat Veisi New J. Chem., 2018,42, 1757-1761
• 4. Exceptional activity of sub-nm Pt clusters on CdS for photocatalytic hydrogen production: a combined experimental and first-principles study?
  Qiyuan Wu,Shangmin Xiong,Peichuan Shen,Shen Zhao,Alexander Orlov Catal. Sci. Technol., 2015,5, 2059-2064
• 5. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Imidazoles Substituted imidazoles

Introduction to 3-(2-Methyl-1H-imidazol-1-yl)propan-1-amine and Its Significance in Modern Chemical Biology

3-(2-Methyl-1H-imidazol-1-yl)propan-1-amine, a compound with the CAS number 2258-21-1, represents a fascinating intersection of organic chemistry and pharmaceutical innovation. This heterocyclic amine derivative has garnered significant attention in recent years due to its versatile applications in drug discovery and chemical biology. The compound's unique structural features, characterized by a 2-methyl-1H-imidazole moiety linked to a propylamine group, make it a valuable scaffold for developing novel therapeutic agents.

The 2-methyl-1H-imidazole ring system is known for its stability and ability to engage in hydrogen bonding, properties that are highly desirable in medicinal chemistry. This structural motif has been extensively explored in the design of small-molecule inhibitors targeting various biological pathways. The propylamine side chain introduces additional functional flexibility, allowing for further derivatization and optimization of pharmacokinetic profiles. Such structural attributes have positioned 3-(2-methyl-1H-imidazol-1-yl)propan-1-amine as a key intermediate in the synthesis of bioactive molecules.

In the realm of pharmaceutical research, 3-(2-methyl-1H-imidazol-1-yl)propan-1-amine has been investigated for its potential role in modulating enzyme activity and receptor interactions. Recent studies have highlighted its utility in the development of compounds targeting inflammatory pathways, particularly those involving cytokine receptors and signal transduction cascades. The imidazole ring's ability to mimic natural biomolecules has enabled the design of selective antagonists that can modulate immune responses without significant off-target effects.

The compound's relevance extends to the field of chemical biology, where it serves as a building block for creating complex molecular probes. Researchers have leveraged its structural framework to develop tools that facilitate the study of protein-protein interactions and post-translational modifications. These probes are essential for unraveling the intricate networks that govern cellular processes, providing insights into disease mechanisms and potential therapeutic interventions.

One of the most compelling aspects of 3-(2-methyl-1H-imidazol-1-yl)propan-1-amine is its adaptability in synthetic chemistry. The presence of both an amine and an imidazole moiety allows for diverse functionalization strategies, including coupling with carboxylic acids via amide bond formation or participating in nucleophilic substitution reactions. This chemical versatility has been exploited in the synthesis of peptidomimetics and other constrained analogs designed to enhance binding affinity and metabolic stability.

The pharmaceutical industry has also shown interest in 3-(2-methyl-1H-imidazol-1-yl)propan-1-amine as a starting material for large-scale production of proprietary drugs. Its well-documented synthetic pathways and favorable physicochemical properties make it an attractive candidate for industrial processes. Moreover, the compound's compatibility with various purification techniques ensures high yields and purity levels, which are critical for regulatory compliance and commercial viability.

Advances in computational chemistry have further enhanced the utility of 3-(2-methyl-1H-imidazol-1-yl)propan-1-amine in drug discovery. Molecular modeling studies have revealed its potential as a scaffold for designing molecules with improved pharmacokinetic profiles, such as enhanced solubility and reduced toxicity. These simulations have guided the optimization of lead compounds, accelerating the transition from bench to bedside.

The compound's role in addressing unmet medical needs has not gone unnoticed by academic researchers. Collaborative efforts between academia and industry have led to innovative applications, particularly in the treatment of rare diseases where traditional drug development approaches have faced challenges. By leveraging the unique properties of 3-(2-methyl-1H-imidazol-1-ylopropanamino), researchers have identified novel therapeutic candidates that are currently undergoing preclinical evaluation.

The future prospects for 3-(2-methyl-lH-imidazol-l-yI)propan-l-amino remain promising as new synthetic methodologies continue to emerge. Advances in flow chemistry and biocatalysis have opened up avenues for more sustainable production processes, reducing waste and energy consumption while maintaining high product quality. These innovations align with global efforts to promote green chemistry principles and ensure environmental responsibility.

In conclusion, 3-(2-methyl-lH-imidazol-l-yI)propan-l-amino (CAS no: 225821) stands as a testament to the power of interdisciplinary research in driving pharmaceutical innovation. Its multifaceted applications across drug discovery, chemical biology, and industrial chemistry underscore its importance as a versatile building block. As scientific understanding continues to evolve, this compound will undoubtedly play an integral role in shaping the future of medicine.

• 13435-22-8(1-Butyl-2-methylimidazole)
• 5709-29-5(1H-Imidazole, 1-dodecyl-2-methyl-)
• 88940-40-3(4-(2-methyl-1H-imidazol-1-yl)butan-1-amine)
• 116680-33-2(2-methyl-1-(2-methylpropyl)-1H-imidazole)
• 218151-78-1(1,2-Dimethyl-3-propylimidazolium Iodide)
• 79319-22-5(3-(2-Methyl-1h-imidazol-1-yl)Propylamine Hydrochloride)
• 98892-74-1(1H-Imidazolium,1,2-dimethyl-3-propyl-, chloride (1:1))
• 42032-30-4(1H-Imidazole,1-decyl-2-methyl-)
• 1059626-18-4(N-Methyl-3-(2-methyl-1H-imidazol-1-yl)-propan-1-amine dihydrochloride)
• 2258-24-4(3-(2-Ethyl-1H-imidazol-1-yl)propan-1-amine)